NHS App: Faster Clinical Trial Access for Patients
- The National Health Service (NHS) App will soon allow patients to find and enroll in clinical trials, part of a broader effort to bolster research participation across the...
- The Department for Health and Social Care (DHSC) saeid the app will eventually match patients to relevant trials using individual health data and preferences, sending push notifications about...
- To increase transparency, the DHSC plans to publish data on trial sponsorships at NHS trusts, universities, and primary care sites.
The UK’s National Health Service (NHS) App is set too revolutionize clinical trial access, dramatically improving patient participation. This ambitious initiative, designed to enhance the United Kingdom’s role in medical research, will allow patients to easily find and enroll in relevant clinical trials using their health data. The Department for Health and Social Care (DHSC) aims to cut red tape and speed up trial setup times, reducing delays through standardized contracts. News Directory 3 reports on the notable economic potential, citing the global clinical trials market’s potential. Learn how this streamlined process will attract investment and accelerate medical breakthroughs. Discover what’s next …
NHS App to Streamline clinical Trial Access, Boost Participation
The National Health Service (NHS) App will soon allow patients to find and enroll in clinical trials, part of a broader effort to bolster research participation across the United Kingdom. The initiative leverages the National Institute for Health and Care Research’s (NIHR) “Be Part of Research” service.
The Department for Health and Social Care (DHSC) saeid the app will eventually match patients to relevant trials using individual health data and preferences, sending push notifications about potentially suitable studies. This aims to improve recruitment for clinical trials.
To increase transparency, the DHSC plans to publish data on trial sponsorships at NHS trusts, universities, and primary care sites. Top-performing sites will be highlighted, while underperforming ones will be identified for advancement. Future government funding will prioritize NHS trusts demonstrating strong support for clinical trials.
The UK has been working to regain its standing as a prime location for clinical trials. The DHSC noted that excessive bureaucracy has slowed trial setup compared to othre countries. Currently, securing separate contracts with each NHS entity can take about 250 days, versus just 100 days in spain.
To combat these delays, the government has pledged a standardized national contract for all trials. This measure is projected to simplify paperwork and reduce setup times to 150 days by March 2026, marking what the DHSC calls the most enterprising timeline reduction in UK history for clinical trials.
Professor Lucy chappell, DHSC chief scientific adviser and NIHR chief executive, said the goal is to establish the UK as a global research hub.
Professor Andrew Morris, president of the Academy of Medical Sciences, emphasized the economic potential.”The global clinical trials market is estimated to be worth at least $80 billion by 2030, and countries that can demonstrate speed, quality, and cost will have a competitive edge,” Morris said.He added that faster setup and improved public access via the NHS App will accelerate the translation of new treatments from “laboratory to bedside.”
The NIHR also launched a nationwide recruitment drive for clinical trials. Nicola Perrin, chief executive of the Association of Medical Research Charities, noted that many UK trials have been hampered by poor recruitment. She welcomed efforts to boost participation from underserved groups.
Morris stressed the importance of inclusivity. “Success will depend on earning trust and addressing the broader barriers to diverse participation,” he said.
What’s next
The NHS App integration and streamlined contracting processes are expected to improve the efficiency and inclusivity of clinical trials in the UK, potentially attracting more investment and accelerating medical advancements.